Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?

Advances in Experimental Medicine and Biology

Volumn 489, Issue , 2001, Pages 13-29

  Nurden, Alan T ^a   Nurden, Paquita ^a   George, James N ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; VITRONECTIN RECEPTOR;

ANTICOAGULATION; ATHEROSCLEROSIS; BERNARD SOULIER DISEASE; BLEEDING; CONFERENCE PAPER; GENE MUTATION; GENETIC DISORDER; GLANZMANN DISEASE; HEMOPHILIA; PRIORITY JOURNAL; SCOTT SYNDROME; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ARTERIOSCLEROSIS; BERNARD-SOULIER SYNDROME; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CYTOKINES; CYTOPLASMIC GRANULES; DISEASE SUSCEPTIBILITY; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; GENETIC HETEROGENEITY; GROWTH SUBSTANCES; HUMANS; MALE; MUTATION; MYOCARDIAL INFARCTION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, VITRONECTIN; SEQUENCE DELETION; THROMBASTHENIA;

EID: 0035034321     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1277-6_2     Document Type: Article

References (56)

1. Inherited abnormalities of platelets
2. Inherited disorders of the platelet membrane: Glanzmann thrombasthenia, Bernard-Soulier syndrome and other disorders
3. Integrin signalling: The platelet paradigm
4. 3 binds prothrombin and influences its activation
5. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'
6. v integrins
7. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel
8. 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
9. Glanzmann thrombasthenia: New insights from an historical perspective
10. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions
11. The molecular genetics of Glanzmann's thrombasthenia
12. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel
13. Double heterozygosity of the GP IIb gene in a Swiss patient with Glanzmann's thrombasthenia
14. 3 integrin subunit association
15. Glanzmann thrombasthenia. Cooperation between sequence variants inCis during splice selection
16. 3) in a Chinese patient with Glanzmann's thrombasthenia
17. Homozygous Cys542→Arg mutation of the GP IIIa gene in a Swiss patient with type I Glanzmann's thrombasthenia
18. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation
19. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann's thrombasthenia
20. 3 complex
21. IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome
22. Glanzmann's thrombasthenia: The spectrum of clinical disease
23. Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin
24. Screening for Factor V Leiden and a prothrombin gene polymorphism in patients with Glanzmann' s thrombasthenia
25. Bernard-Soulier syndrome
26. Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes
27. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
28. Characterization of the initial α-thrombin interaction with glycoprotein Ibα in relation to platelet activation
29. A dual thrombin receptor system for platelet activation
30. Bernard-Soulier syndrome: Quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements
31. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex
32. Bernard-Soulier syndrome Kagoshima: Ser444 →stop mutation of glycoprotein (GP) Ibα resulting in circulating truncated GP Ibα and surface expression of GPIbβ and GPIX
33. Cys209Ser mutation in the platelet membrane glycoprotein Ibα gene is associated with Bernard-Soulier syndrome
34. Identification of a patient with a Bernard-Soulier syndrome and a deletion in the DiGeorge/Velo-cardio-facial chromosomal region in 22q11.2
35. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibβ promoter resulting in the Bernard-Soulier syndrome
36. Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome
37. Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX
38. Point mutation in a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome
39. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease
40. A three-base deletion removing a leucine residue in a leucine-rich repeat of platelet glycoprotein Ibα associated with a variant of Bernard-Soulier syndrome (Nancy I)
41. Missense mutations of the glycoprotein (GP) Ibβ gene impairing the GPIb α/β disulfide linkage in a family with giant platelet disorder
42. Atherosclerosis and unstable angina in Bernard-Soulier syndrome
43. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading
44. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion
45. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor
46. 1 density
47. Platelet surface collagen receptor polymorphisms: Variable receptor expression and thrombotic/hemorrhagic risk
48. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
49. Purinoceptors on blood platelets: Further pharmacological and clinical evidence to suggest the presence of two ADP receptors
50. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets
51. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets
52. 60 to Leu mutation
53. Inherited disorders of platelet α-granules
54. Heterogeneous abnormalities of platelet dense granule ultrastructure in 20 patients with congenital storage pool deficiency
55. Molecular genetics of the Hermansky-Pudlak and Chediak-Higashi syndromes
56. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: A study using physiologic agonists and local anaesthetics